Anti-infection


Anti-infectives are agents that eliminate or inhibit the spread of infectious organisms, encompassing antibiotics, antifungals, antivirals, and antiprotozoals.
Antibiotics are a class of antimicrobial agents specifically designed to target bacterial pathogens. They exert their effects by interfering with essential bacterial processes such as cell wall synthesis, protein synthesis, nucleic acid replication, and metabolic pathways, thereby either inhibiting bacterial growth or inducing bacterial death.
Antifungals are antimicrobial agents employed to combat fungal infections (mycoses) in humans and animals. Common antifungal classes include azoles, polyenes, echinocandins, and allylamines, which function by disrupting unique fungal structures or pathways, such as the synthesis or integrity of ergosterol-containing cell membranes and β-glucan-based cell walls, or by interfering with nucleic acid or protein synthesis.
Antivirals are compounds developed to inhibit the replication and spread of viruses within host organisms. Antivirals typically act by blocking viral entry, genome replication, protein processing, or virion assembly and release. Representative examples include nucleoside analogs, protease inhibitors, and neuraminidase inhibitors.
Antiprotozoals are drugs used to treat infections caused by protozoan parasites, including malaria, amebiasis, giardiasis, and trypanosomiasis. They act through a variety of mechanisms, including inhibition of nucleic acid synthesis, interference with mitochondrial function, and disruption of heme detoxification pathways in susceptible parasites.
-
BA2109 ACT-451840Summary: ACT-451840 is an orally active, potent, low-toxicity compound with activity against both sensitive and resistant strains of Plasmodium falciparum. -
BA2110 GNF179Summary: GNF179 is an optimized 8,8-dimethylimidazolopiperazine analog with antimalarial activity. -
BA2111 SpirodiclofenSummary: Spirodiclofen is a broad-spectrum acaricide. -
BA2112 CWHM-1008Summary: CWHM-1008 is an effective, orally available anti-malarial agent. -
BA2113 JaspamycinSummary: Jaspamycin (7-CN-7-C-Ino) is a potent activator. -
BA2114 N-p-trans-CoumaroyltyramineSummary: N-p-trans-Coumaroyltyramine is a cinnamoylphenethylamide isolated from Polygonum cinnamoylphenethylamide. -
BA2115 ML251Summary: ML251 is a potent nanomolar and phosphofructokinase inhibitor that inhibits (=0.37 μM) and (=0.13 μM). -
BA2116 ModoflanerSummary: Modoflaner is a m-toluene diamide insecticide. -
BA2117 DNDI-6174Summary: DNDI-6174 is a cytochrome bc1 complex inhibitor with potent in vitro activity against a wide range of Leishmania protozoa. -
BA2118 ICASummary: ICA (N-(pyridin-2-yl)-4-(pyridin-2-yl)thiazol-2-amine) is an SK channel inhibitor.

